Parallax Volatility Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,400
Closed -$5.4M 1595
2025
Q4
$5.4M Buy
15,400
+400
+3% +$135K 0.01% 647
2025
Q3
$4.85M Buy
+15,000
New +$4.67M 0.01% 686
2025
Q2
Sell
-2,300
Closed -$1M 1622
2025
Q1
$1M Buy
+2,300
New +$923K ﹤0.01% 1052
2024
Q4
Sell
-1,300
Closed -$676K 2100
2024
Q3
$676K Buy
1,300
+300
+30% +$160K ﹤0.01% 1453
2024
Q2
$542K Sell
1,000
-14,000
-93% -$7.4M ﹤0.01% 1420
2024
Q1
$7.78M Buy
15,000
+7,400
+97% +$3.68M 0.02% 588
2023
Q4
$3.58M Hold
7,600
0.01% 951
2023
Q3
$3.31M Sell
7,600
-700
-8% -$318K 0.01% 913
2023
Q2
$3.69M Sell
8,300
-17,900
-68% -$8.26M 0.01% 907
2023
Q1
$12M Sell
26,200
-43,000
-62% -$20.5M 0.02% 524
2022
Q4
$35.5M Sell
69,200
-4,700
-6% -$2.39M 0.06% 360
2022
Q3
$33.6M Buy
73,900
+50,700
+219% +$24.3M 0.05% 385
2022
Q2
$11.2M Buy
23,200
+22,200
+2,220% +$11M 0.01% 685
2022
Q1
$491K Buy
+1,000
New +$457K ﹤0.01% 1911
2020
Q4
Sell
-228,800
Closed -$61.5M 2869
2020
Q3
$61.5M Buy
228,800
+102,900
+82% +$27.7M 0.05% 349
2020
Q2
$33.1M Buy
125,900
+49,800
+65% +$13.3M 0.04% 367
2020
Q1
$17.3M Buy
76,100
+26,400
+53% +$7.19M 0.02% 440
2019
Q4
$15M Buy
49,700
+47,000
+1,741% +$12.9M 0.02% 515
2019
Q3
$648K Sell
2,700
-41,800
-94% -$11.5M ﹤0.01% 1537
2019
Q2
$12.6M Buy
44,500
+32,000
+256% +$8.74M 0.01% 465
2019
Q1
$3.59M Sell
12,500
-75,700
-86% -$21.9M ﹤0.01% 785
2018
Q4
$23.2M Buy
88,200
+52,200
+145% +$14.4M 0.03% 314
2018
Q3
$9.87M Buy
+36,000
New +$9.35M 0.01% 484
2016
Q2
Sell
-200
Closed -$28K 2717
2016
Q1
$28K Sell
200
-300
-60% -$40.1K ﹤0.01% 2245
2015
Q4
$70K Buy
+500
New +$68.9K ﹤0.01% 2238
2015
Q3
Sell
-200
Closed -$33K 3135
2015
Q2
$33K Sell
200
-3,200
-94% -$511K ﹤0.01% 2712
2015
Q1
$523K Sell
3,400
-45,300
-93% -$6.45M ﹤0.01% 1529
2014
Q4
$6.12M Sell
48,700
-87,700
-64% -$10.8M 0.02% 621
2014
Q3
$16.3M Buy
136,400
+126,700
+1,306% +$14.5M 0.05% 316
2014
Q2
$1.04M Sell
9,700
-2,700
-22% -$278K ﹤0.01% 1018
2014
Q1
$1.24M Buy
12,400
+800
+7% +$72.4K 0.01% 712
2013
Q4
$1.07M Sell
11,600
-2,900
-20% -$258K 0.01% 825
2013
Q3
$1.21M Buy
14,500
+9,600
+196% +$823K 0.01% 630
2013
Q2
$402K Buy
+4,900
New +$367K ﹤0.01% 869

Other funds holding ELV

Parallax Volatility Advisers's ELV Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,576 shares — an estimated $552K sold.

Parallax Volatility Advisers first reported a position in ELV in Q2 2013 and held it in 29 quarters. The position peaked at $15.3M in Q3 2020. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,576 Elevance Health shares in Q1 2026, an estimated $552K.
  • Parallax Volatility Advisers first reported a position in Elevance Health in Q2 2013 and held it in 29 quarters.
  • Parallax Volatility Advisers's Elevance Health position peaked at $15.3M in Q3 2020.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.